Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Fox Corporation FOX Fundamental Headwinds Point to Subpar RiskReward With HigherGrowth Alternatives Available Prologis Inc PLD Reports Solid Q1 2026 FFO Beat Driven by Resilient Industrial Leasing Demand Invesco Optimum Yield Diversified Commodity Strategy No K1 ETF PDBC Strong YTD Rally Masks Elevated Distribution Risk for IncomeFocused Investors The strategic moves Caris CAI is making now Modest Uptick 20260505 Michael Burry Warns of Parabolic Tech Stocks Reduce Positions Almost Entirely Minerva Neurosciences NERV Slides 522 as Selling Pressure Mounts 20260515 Airgain AIRG Q1 2026 Results Fall Short EPS 008 Revenue NA Veru VERU Delivers Q1 2026 Beat EPS 012 vs 029 Expected Australian Taxpayers Subsidise Big Minings Fossil Fuel Use by 4bn a Year Report Reveals Genpact CEO Highlights AIDriven Reduction in IT Workload and Employment Growth Bernstein Reaffirms Outperform Rating on UnitedHealth Amid PBM Transparency Initiative Weighing the Medicare Premium Consequences of a 235000 Roth IRA Conversion UK Exports to US Tumble 25 as Trump Tariffs Reshape Trade Dynamics BP Ousts Chairman Albert Manifold Extending Boardroom Turmoil SIFY Q4 2024 Earnings EPS Surprise Beats Estimates Stock Slides MGM Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Shares Rally TECX Q1 2026 Earnings EPS Miss as PreCommercial Biotech Advances Pipeline ENR Q1 2026 Earnings Stellar EPS Beat Propels Shares Higher Largo Inc LGO Q1 2026 Earnings Narrower Loss Reported Amid Quiet Market Reaction BBLG Q1 2026 Earnings EPS Surprises to the Upside Despite No Revenue Stock Declines Scage Future SCAG Slides 4 Nears Critical Support at 047 Microbot Medical MBOT Surges Over 5 as Shares Test Key Resistance Level Ocular Therapeutix OCUL Slips Slightly as Stock Holds Key Support at 775 Tyra Biosciences Inc TYRA Faces Modest Decline as Shares Test Key Support Zone NewMarket Corp NEU Edges Higher as Shares Consolidate Above Key Support Definium Therapeutics DFTX Slips 066 as Shares Test Key Support Zone GIII Apparel Group GIII Gains 115 as Shares Test Key Resistance Levels Verastem VSTM Slips Slightly Navigating Support and Resistance at 424 Great Elm Capital Corp GECC Shows Resilience with 191 Gain Nears Resistance My Size Inc MYSZ Edges Higher as Price Holds Near Support Level